Cargando…
Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review
OBJECTIVE: To aid trialists, systematic reviewers and others, we evaluated the degree of standardisation of control measure reporting that has occurred in atrial fibrillation (AF) and venous thromboembolism (VTE) studies since 2000; and attempted to determine whether the prior recommendation of repo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067815/ https://www.ncbi.nlm.nih.gov/pubmed/24951111 http://dx.doi.org/10.1136/bmjopen-2014-005379 |
_version_ | 1782322341004443648 |
---|---|
author | Mearns, Elizabeth S Hawthorne, Jessica Song, Ju-Sung Coleman, Craig I |
author_facet | Mearns, Elizabeth S Hawthorne, Jessica Song, Ju-Sung Coleman, Craig I |
author_sort | Mearns, Elizabeth S |
collection | PubMed |
description | OBJECTIVE: To aid trialists, systematic reviewers and others, we evaluated the degree of standardisation of control measure reporting that has occurred in atrial fibrillation (AF) and venous thromboembolism (VTE) studies since 2000; and attempted to determine whether the prior recommendation of reporting ≥2 measures per study has been employed. DESIGN: Systematic review. SEARCH STRATEGY: We searched bibliographic databases (2000 to June 2013) to identify AF and VTE studies evaluating dose-adjusted vitamin K antagonists (VKAs) and reporting ≥1 control measure. The types of measures reported, proportion of studies reporting ≥2 measures and mean (±SD) number of measures per study were determined for all studies and compared between subgroups. DATA EXTRACTION: Through the use of a standardised data extraction tool, we independently extracted all data, with disagreements resolved by a separate investigator. RESULTS: 148 studies were included, 57% of which reported ≥2 control measures (mean/study=2.13±1.36). The proportion of time spent in the target international normalised ratio range (TTR) was most commonly reported (79%), and was frequently accompanied by time above/below range (52%). AF studies more frequently reported ≥2 control measures compared with VTE studies (63% vs 37%; p=0.004), and reported a greater number of measures per study (mean=2.36 vs 1.53; p<0.001). Observational studies were more likely to provide ≥2 measures compared with randomised trials (76% vs 33%; p<0.001) and report a greater number of measures (mean=2.58 vs 1.63; p<0.001). More recent studies (2004–2013) reported ≥2 measures more often than older (2000–2003) studies (59% vs 35%; p=0.05) and reported more measures per study (mean=2.23 vs 1.48; p=0.02). CONCLUSIONS: While TTR was often utilised, studies reported ≥2 measures of VKA control only about half of the time and lacked consistency in the types of measures reported. A trend towards studies reporting greater numbers of VKA control measures over time was observed over our review time horizon, particularly, with AF and observational studies. |
format | Online Article Text |
id | pubmed-4067815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40678152014-06-25 Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review Mearns, Elizabeth S Hawthorne, Jessica Song, Ju-Sung Coleman, Craig I BMJ Open Cardiovascular Medicine OBJECTIVE: To aid trialists, systematic reviewers and others, we evaluated the degree of standardisation of control measure reporting that has occurred in atrial fibrillation (AF) and venous thromboembolism (VTE) studies since 2000; and attempted to determine whether the prior recommendation of reporting ≥2 measures per study has been employed. DESIGN: Systematic review. SEARCH STRATEGY: We searched bibliographic databases (2000 to June 2013) to identify AF and VTE studies evaluating dose-adjusted vitamin K antagonists (VKAs) and reporting ≥1 control measure. The types of measures reported, proportion of studies reporting ≥2 measures and mean (±SD) number of measures per study were determined for all studies and compared between subgroups. DATA EXTRACTION: Through the use of a standardised data extraction tool, we independently extracted all data, with disagreements resolved by a separate investigator. RESULTS: 148 studies were included, 57% of which reported ≥2 control measures (mean/study=2.13±1.36). The proportion of time spent in the target international normalised ratio range (TTR) was most commonly reported (79%), and was frequently accompanied by time above/below range (52%). AF studies more frequently reported ≥2 control measures compared with VTE studies (63% vs 37%; p=0.004), and reported a greater number of measures per study (mean=2.36 vs 1.53; p<0.001). Observational studies were more likely to provide ≥2 measures compared with randomised trials (76% vs 33%; p<0.001) and report a greater number of measures (mean=2.58 vs 1.63; p<0.001). More recent studies (2004–2013) reported ≥2 measures more often than older (2000–2003) studies (59% vs 35%; p=0.05) and reported more measures per study (mean=2.23 vs 1.48; p=0.02). CONCLUSIONS: While TTR was often utilised, studies reported ≥2 measures of VKA control only about half of the time and lacked consistency in the types of measures reported. A trend towards studies reporting greater numbers of VKA control measures over time was observed over our review time horizon, particularly, with AF and observational studies. BMJ Publishing Group 2014-06-20 /pmc/articles/PMC4067815/ /pubmed/24951111 http://dx.doi.org/10.1136/bmjopen-2014-005379 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Cardiovascular Medicine Mearns, Elizabeth S Hawthorne, Jessica Song, Ju-Sung Coleman, Craig I Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
title | Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
title_full | Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
title_fullStr | Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
title_full_unstemmed | Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
title_short | Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
title_sort | measures of vitamin k antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067815/ https://www.ncbi.nlm.nih.gov/pubmed/24951111 http://dx.doi.org/10.1136/bmjopen-2014-005379 |
work_keys_str_mv | AT mearnselizabeths measuresofvitaminkantagonistcontrolreportedinatrialfibrillationandvenousthromboembolismstudiesasystematicreview AT hawthornejessica measuresofvitaminkantagonistcontrolreportedinatrialfibrillationandvenousthromboembolismstudiesasystematicreview AT songjusung measuresofvitaminkantagonistcontrolreportedinatrialfibrillationandvenousthromboembolismstudiesasystematicreview AT colemancraigi measuresofvitaminkantagonistcontrolreportedinatrialfibrillationandvenousthromboembolismstudiesasystematicreview |